Last reviewed · How we verify
NCT05665049: STEB
Social Transfers for Exclusive Breastfeeding
NA trial testing Social Transfer in Breast Feeding, Exclusive in 300 participants. Participants enrolled and being followed up; not accepting new ones.
30 October 2023
Quick facts
| Lead sponsor | Swiss Tropical & Public Health Institute |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 300 |
| Start date | 1 August 2022 |
| Primary completion | 30 October 2023 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Laos |
Drugs / interventions tested
- Social Transfer
Conditions studied
- Breast Feeding, Exclusive — all drugs for Breast Feeding, Exclusive →
- Breastfeeding — all drugs for Breastfeeding →
- Development, Child — all drugs for Development, Child →
- Development, Infant — all drugs for Development, Infant →
Sponsor
Swiss Tropical & Public Health Institute
Who can join
Adults 18 to 42, female only, with Breast Feeding, Exclusive or Breastfeeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to assess the effectiveness of social transfers on exclusive breastfeeding rates in Lao PDR. The main questions it aims to answer are: 1. Are social transfers effective at increasing exclusive breastfeeding rates at 6-months 2. Are social transfers cost-effective 3. What are the long-term impacts of social transfers for breastfeeding on child development Participants will be randomly assigned to one of three groups: 1) control, no social transfer 2) non-conditional social transfer at 6-months postpartum, and 3) conditional social transfer at six months postpartum; conditional upon the mothers exclusive breastfeeding status. All participants receive education about the benefits of exclusive breastfeeding and current international recommendations. Researchers will compare the intervention groups to the control group to see if social transfers are effective at increasing exclusive breastfeeding rates at six months postpartum.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Social Transfers for Exclusive Breastfeeding (STEB) Intervention in Lao People's Democratic Republic: Protocol for a Randomized Controlled Trial.
Sonephet S, Kounnavong S, Zinsstag L, Vonaesch P, et al · · 2024 · cited 5× · PMID 38700928 · DOI 10.2196/54768 -
Conditional and Unconditional Social Transfers, Early-Life Nutrition, and Child Growth: A Randomized Clinical Trial.
Wallenborn JT, Sonephet S, Sayasone S, Siengsounthone L, et al · · 2025 · cited 3× · PMID 39680397 · DOI 10.1001/jamapediatrics.2024.5079
Verify or expand the search:
- PubMed search for NCT05665049
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Feeding, Exclusive
Currently open trials in the same condition.
- NCT05486663 — Tactile/kinesthetic Stimulus Program · NA · recruiting
Other Swiss Tropical & Public Health Institute trials
Trials by the same sponsor.
- NCT06606860 — Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets · Phase 1 · completed
- NCT06373835 — Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis · Phase 2 · completed
- NCT06304831 — Use of Facility Ratings to Improve Satisfaction With Heath Care for Children · NA · completed
- NCT05644067 — Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic C · Phase 1 · completed
- NCT06648603 — Citizen Action for Sustainable Dengue Control in Sub-Saharan Africa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05665049 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Swiss Tropical & Public Health Institute
- Last refreshed: 13 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05665049.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing